Efficacy and safety of tirzepatide in subjects with type 2 diabetes and chronic kidney disease: a prospective, two-arm observational study.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- Efficacy and safety of tirzepatide in subjects with type 2 diabetes and chronic kidney disease: a prospective, two-arm observational study.
- Published In:
- Therapeutic advances in endocrinology and metabolism, 16, 20420188251378216 (2025)
- Authors:
- Oe, Yuki, Nomoto, Hiroshi, Cho, Kyu Yong, Omori, Takashi, Nakamura, Koki, Takahashi, Akihiro, Suzuki, Yuka, Yoshikawa, Jyunpei, Kato-Sato, Akiko, Furukawa, Shin, Nishio, Taro, Kitakawa, Hirohiko, Miya, Aika, Kameda, Hiraku, Nakazawa, Daigo, Nakamura, Akinobu, Sakai, Kiyoshi, Atsumi, Tatsuya
- Database ID:
- RPEP-12842
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-12842APA
Oe, Yuki; Nomoto, Hiroshi; Cho, Kyu Yong; Omori, Takashi; Nakamura, Koki; Takahashi, Akihiro; Suzuki, Yuka; Yoshikawa, Jyunpei; Kato-Sato, Akiko; Furukawa, Shin; Nishio, Taro; Kitakawa, Hirohiko; Miya, Aika; Kameda, Hiraku; Nakazawa, Daigo; Nakamura, Akinobu; Sakai, Kiyoshi; Atsumi, Tatsuya. (2025). Efficacy and safety of tirzepatide in subjects with type 2 diabetes and chronic kidney disease: a prospective, two-arm observational study.. Therapeutic advances in endocrinology and metabolism, 16, 20420188251378216. https://doi.org/10.1177/20420188251378216
MLA
Oe, Yuki, et al. "Efficacy and safety of tirzepatide in subjects with type 2 diabetes and chronic kidney disease: a prospective, two-arm observational study.." Therapeutic advances in endocrinology and metabolism, 2025. https://doi.org/10.1177/20420188251378216
RethinkPeptides
RethinkPeptides Research Database. "Efficacy and safety of tirzepatide in subjects with type 2 d..." RPEP-12842. Retrieved from https://rethinkpeptides.com/research/oe-2025-efficacy-and-safety-of
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.